Jennison Associates’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$98.7M Buy
1,698,011
+1,020,458
+151% +$55.4M 0.07% 138
2025
Q4
$31.3M Sell
677,553
-493,346
-42% -$22.1M 0.02% 273
2025
Q3
$42.2M Sell
1,170,899
-228,400
-16% -$7.57M 0.02% 245
2025
Q2
$45.5M Buy
1,399,299
+273,579
+24% +$8.97M 0.03% 233
2025
Q1
$42.5M Sell
1,125,720
-120,831
-10% -$9.66M 0.03% 234
2024
Q4
$102M Buy
1,246,551
+9,121
+0.7% +$906K 0.06% 141
2024
Q3
$141M Sell
1,237,430
-145,701
-11% -$13.1M 0.09% 95
2024
Q2
$104M Buy
1,383,131
+126,248
+10% +$8.59M 0.07% 120
2024
Q1
$85.9M Sell
1,256,883
-219,271
-15% -$15.2M 0.06% 136
2023
Q4
$92.7M Sell
1,476,154
-278,537
-16% -$14.5M 0.07% 122
2023
Q3
$89.5M Buy
1,754,691
+300,189
+21% +$14.8M 0.08% 118
2023
Q2
$72.6M Buy
1,454,502
+24,463
+2% +$1.16M 0.06% 144
2023
Q1
$53.6M Buy
1,430,039
+8,032
+0.6% +$341K 0.05% 175
2022
Q4
$68.2M Buy
+1,422,007
New +$55.8M 0.07% 151

Other funds holding PCVX